Reactive oxygen species (ROS) have pivotal roles in modulating multiple physiological processes of living organisms. Benefiting from the emerging advances in biotechnology, numerous nanomaterials with specific ROS-regulating features have been exploited to orient the dynamic behaviors of ROS in biological microenvironments, which results in the occurrence of cutting-edge therapeutic methodologies, such as nanomaterial-enabling in vivo ROS generation for therapy. The mounting focus on biomedical researches of nanocatalytic materials has contributed to the evolution of “nanocatalytic medicine” concept, which is envisaged to facilitate the advance of such subdiscipline of biomedical engineering. The specificity and high-efficiency of nanocatalysis can be translated into high-effectiveness and alleviated side effects in therapeutic practices by employing “nanocatalytic medicine” to design catalytic processes for optimized treatment outcomes.
In this Research Topic, the cutting-edge researches concerning emerged advances on ROS-related nanocatalytic medicine will be outlined, with highlights on underlying material science of nanomaterials by ROS generation or scavenging for enhanced treatment outcomes. Furthermore, key scientific issues in the progress of free radical-based cross-disciplinary science will be presented, aiming to reveal the internal mechanisms of reactive oxygen species for nanocatalytic therapeutic modalities. We expect that the launch of Topic on this expanded field “nanocatalytic medicine” will be is favorable for the future development of ROS-based cross-disciplinary researches and clinical translations.
Given that pronounced progresses have sparked great interests in the past decades, and current explorations in this field, especially in reactive oxygen species-based nanocatalytic medicine, is still under in-depth study, in this Research Topic, we will collect the essential chemical theories of diverse reactive oxygen species-based therapeutic strategies comprehensively. The current Research Topic aims to cover promising, recent, and novel research trends in ROS-based nanocatalytic medicine. Areas to be covered in this Research Topic may include, but are not limited to:
• Design and construction of nanocatalyst for ROS-related diseases;
• Catalytic mechanism of nanocatalyst for ROS-related diseases;
• Biological effects of nanocatalyst for ROS-related diseases;
• Structure activity relationship of nanocatalyst for ROS-related diseases;
• Nanocatalyst in the diagnosis and treatment of ROS-related diseases;
• The mechanism of nanocatalyst in the diagnosis and treatment of ROS-related diseases.
Keywords:
reactive oxygen species, inflammation, nanomedicine, nanomaterial, nanocatalyst
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Reactive oxygen species (ROS) have pivotal roles in modulating multiple physiological processes of living organisms. Benefiting from the emerging advances in biotechnology, numerous nanomaterials with specific ROS-regulating features have been exploited to orient the dynamic behaviors of ROS in biological microenvironments, which results in the occurrence of cutting-edge therapeutic methodologies, such as nanomaterial-enabling in vivo ROS generation for therapy. The mounting focus on biomedical researches of nanocatalytic materials has contributed to the evolution of “nanocatalytic medicine” concept, which is envisaged to facilitate the advance of such subdiscipline of biomedical engineering. The specificity and high-efficiency of nanocatalysis can be translated into high-effectiveness and alleviated side effects in therapeutic practices by employing “nanocatalytic medicine” to design catalytic processes for optimized treatment outcomes.
In this Research Topic, the cutting-edge researches concerning emerged advances on ROS-related nanocatalytic medicine will be outlined, with highlights on underlying material science of nanomaterials by ROS generation or scavenging for enhanced treatment outcomes. Furthermore, key scientific issues in the progress of free radical-based cross-disciplinary science will be presented, aiming to reveal the internal mechanisms of reactive oxygen species for nanocatalytic therapeutic modalities. We expect that the launch of Topic on this expanded field “nanocatalytic medicine” will be is favorable for the future development of ROS-based cross-disciplinary researches and clinical translations.
Given that pronounced progresses have sparked great interests in the past decades, and current explorations in this field, especially in reactive oxygen species-based nanocatalytic medicine, is still under in-depth study, in this Research Topic, we will collect the essential chemical theories of diverse reactive oxygen species-based therapeutic strategies comprehensively. The current Research Topic aims to cover promising, recent, and novel research trends in ROS-based nanocatalytic medicine. Areas to be covered in this Research Topic may include, but are not limited to:
• Design and construction of nanocatalyst for ROS-related diseases;
• Catalytic mechanism of nanocatalyst for ROS-related diseases;
• Biological effects of nanocatalyst for ROS-related diseases;
• Structure activity relationship of nanocatalyst for ROS-related diseases;
• Nanocatalyst in the diagnosis and treatment of ROS-related diseases;
• The mechanism of nanocatalyst in the diagnosis and treatment of ROS-related diseases.
Keywords:
reactive oxygen species, inflammation, nanomedicine, nanomaterial, nanocatalyst
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.